Journals / European Journal of Biology / 2026 / Volume: 85 Issue: 2

Design of Experiments–Driven Purification of Anti-Vascular Endothelial Growth Factor Monoclonal Antibodies

Ulku Yilmaz Sahin(R&D Center, Arven Pharmaceuticals)0000-0003-2601-2109
Pages
—
Publication Date
2026-06-12
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purified mAbs were confirmed based on their mass values using the sodium dodecyl sulphate–polyacrylamide gel electrophoresis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study demonstrated the successful application of multimodal chromatography (MMC) as an alternative to protein A chromatography for the purification of mAbs with anti-vascular endothelial growth factor properties.
📊
Key Findings & Data:The experimental designs for the purification steps were developed using Modde 13 software, and the resulting data were analysed with the assistance of the same software.
💡
Conclusion & Impact:The purified mAbs were confirmed based on their mass values using the sodium dodecyl sulphate–polyacrylamide gel electrophoresis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Vascular endothelial growth factor · Chinese hamster ovary cells · Monoclonal antibody purification

Abstract

Objective: This study demonstrated the successful application of multimodal chromatography (MMC) as an alternative to protein A chromatography for the purification of mAbs with anti-vascular endothelial growth factor properties. Materials and Methods: PROchievA and mAbSelect PrismA resins were used for protein A chromatographic purification, while Capto MMC and Nuvia cPrime resins were used for multimodal chromatographic purification. Each purification study was conducted as the initial capture step for the mAb produced in the Chinese hamster ovary cell culture. The experimental designs for the purification steps were developed using Modde 13 software, and the resulting data were analysed with the assistance of the same software. Results: Purification steps using protein A resins resulted in yields of approximately 87.2%–93%, whereas yields obtained with multimodal resins were approximately 57.8%–65.2%. The multimodal purification step enabled the production of a monoclonal antibody (mAb) with a higher purity compared to the protein A purification step. It also showed superior performance compared to protein A resins in the removal of acidic and basic variants, achieving approximately 10% greater reduction of these variants in a single step and enabling the production of a purer mAb product. Conclusion: This study highlighted the potential of MMC to enhance the purity of mAbs with greater efficiency in removing charge variants. The purified mAbs were confirmed based on their mass values using the sodium dodecyl sulphate–polyacrylamide gel electrophoresis.

🔖

Cite This Article

Topaloğlu, Y., Sahin, U. Y., Yarat, A. (2026). Design of Experiments–Driven Purification of Anti-Vascular Endothelial Growth Factor Monoclonal Antibodies. European Journal of Biology, Volume: 85 Issue: 2. https://doi.org/10.26650/EurJBiol.2026.1842218

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (37)

  1. Posner J, Barrington P, Brier T, Datta-Mannan A. Monoclonal antibodies: Past, present and future. Handb Exp Pharmacol. 2019;260:81-141. doi:10.1007/164_2019_323 google scholar
  2. Henricks LM, Schellens JH, Huitema AD, Beijnen JH. The use of combinations of monoclonal antibodies in clinical oncology. Cancer Treat Rev. 2015;41(10):859– 867. doi:10.1016/j.ctrv.2015.10.008 google scholar
  3. Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer. 1999;85(1):178–187. doi:10.1002/(SICI)1097-0142(19990101)85:1 3.0.CO;2-7google scholar
  4. Justiz-Vaillant A, Pandit BR, Unakal C, Vuma S, Akpaka PE. A comprehensive review about the use of monoclonal antibodies in cancer therapy. Antibodies (Basel). 2025;14(2):35. doi:10.3390/antib14020035google scholar
  5. Wilchek M, Chaiken I. An overview of affinity chromatography. Methods Mol Biol. 2000;147:1-6.google scholar
  6. Kumpalume P, Ghose S. Chromatography: The high-resolution technique for protein separation. In: Hatti-Kaul R, Mattiasson B, eds. Isolation and Purification of Proteins. 1st ed. New York, NY: Marcel Dekker; 2003:29-56. google scholar
  7. Wang FA, Fan Y, Chung WK, et al. Evaluation of mild pH elution protein A resins for antibodies and Fc-fusion proteins. J Chromatogr A. 2024;1713:464523. doi:10.1016/j.chroma.2023.464523 google scholar
  8. Siwak M. Platform purification of six biosimilar molecules using Amsphere A3 Protein A resin. BioProcess Int. 2016;14:42–43. google scholar
  9. Zarrineh M, Mashhadi IS, Farhadpour M, Ghassempour A. Mechanism of antibodies purification by protein A. Anal Biochem;. 2020;609:113909. doi:10.1016/j.ab.2020.113909 google scholar
  10. Kallberg K, Johansson HO, Bulow L. Multimodal chromatography: An efficient tool in downstream processing of proteins. Biotechnol J. 2012;7(12):1485-1495. doi:10.1002/biot.201200074 google scholar
  11. Voitl A, Müller-Späth T, Morbidelli M. Application of mixed mode resins for the purification of antibodies. J Chromatogr A. 2010;1217(37):5753-5760. doi:10.1016/ j.chroma.2010.06.047 google scholar
  12. Robinson J, Vats M, Hartmann M. Implementation of multimodal anion exchange chromatography to address product quality challenges and downstream platform limitations: A case study. J Chromatogr A. 2025;1746,465784. doi:10.1016/j.chroma.2025.465784google scholar
  13. Khawli LA, Goswami S, Hutchinson R, et al. Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats. MAbs. 2010;2(6):613–624. doi:10.4161/mabs.2.6.13333.google scholar
  14. Politis NS, Colombo P, Colombo G, Rekkas MD. Design of experiments (DoE) in pharmaceutical development. Drug Dev Ind Pharm. 2017;43(6):889–901. doi:10.1080/03639045.2017.1291672 google scholar
  15. Pan X, Streefland M, Dalm C, Wijffels RH, Martens DE. Selection of chemically defined media for CHO cell fed-batch culture processes. Cytotechnology. 2017;69:39-56. doi:10.1007/s10616-016-0036-5 google scholar
  16. Tscheliessnig A, Jungbauer A. High-performance monolith affinity chromatography for fast quantitation of immunoglobulin G. J Chromatogr A. 2009;1216(13):2676-2682. doi:10.1016/j.chroma.2008.07.063 google scholar
  17. Thakkar SV, Allegre KM, Joshi SB, Volkin DB, Middaugh CR. An application of ultraviolet spectroscopy to study interactions in proteins solutions at high concentrations. J Pharm Sci. 2012;101(9):3051-3061. doi:10.1002/jps.23188 google scholar
  18. Capto MMC Multimodal resin. Cytiva website. https://cdn.cytivalifesciences.com/api/public/content/digi-13734df?_gl=1lple98_gcl_au*OTU3MjY2MDM 3LjE2OTk4MTU3MzY. Accessed June 12, 2023. google scholar
  19. Purification of recombinant proteins on Nuvia cPrime hydrophobic cation exchange media: A simple approach to method development. Bio-Rad Laboratories website. https://www.biorad.com/sites/default/files/webroot/web/pdf/lsr/literature/Bulletin_6418.pdf. Accessed May 3, 2023. google scholar
  20. Do T, Ho F, Heidecker B, Witte K, Chang L, Lerner L. A rapid method for determining dynamic binding capacity of resins for the purification of proteins. Protein Expr Purif. 2008;60(2):147-150. doi:10.1016/j.pep.2008.04.009 google scholar
  21. Angkawinitwong U, Awwad S, Khaw PT, Brocchini S, Williams GR. Electrospun formulations of bevacizumab for sustained release in the eye. Acta Biomater. 2017;64:126-136. doi:10.1016/j.actbio.2017.10.015 google scholar
  22. DiLeo M, Ley A, Nixon AE, Chen J. Choices of capture chromatography technology in antibody manufacturing processes. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1068:136-148. doi:10.1016/j.jchromb.2017.09.050 google scholar
  23. Katterle B. How stable are new biologics? Eurofins BioPharma Product Testing Munich GmbH website. Published 2018. https://www.eurofins.de/media/2849085/pi8011_1620_katterle_11-18_04dez18.pdf. Accessed March 6, 2023. google scholar
  24. Zhang T, Quan C, Dong MW. HPLC for characterization and quality control of therapeutic monoclonal antibodies. LCGC North Am. 2014;32(10):796-808. google scholar
  25. Du Y, Walsh A, Ehrick R, Xu W, May K, Liu H. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. MAbs. 2012;4(5):578-585. doi:10.4161/mabs.21328 google scholar
  26. Yüce M, Sert F, Torabfam M, et al. Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis. Anal Chim Acta. 2021;1152:238189. doi:10.1016/j.aca.2020.12.064 google scholar
  27. SDS-PAGE protocol for protein analysis and antibody validation. NeoBiotechnologies website.https://www.neobiotechnologies.com/protocol/ sds-page-protocol/?srsltid=AfmBOopiSW_MerYO1f62_EO2PvItpuTMogzSpooiVZ LUefbxjGLmx3ee.Accessed June 12, 2023.google scholar
  28. Kirley TL, Norman AB. Unfolding of IgG domains detected by non-reducing SDS-PAGE. Biochem Biophys Res Commun. 2018;503(2):944-949. doi:10.1016/ j.bbrc.2018.06.100 google scholar
  29. Spadiut O, Capone S, Krainer F, Glieder A, Herwig C. Microbials for the production of monoclonal antibodies and antibody fragments. Trends Biotechnol. 2014;32(1):54-60. doi:10.1016/j.tibtech.2013.10.002 google scholar
  30. Walsh G. Biopharmaceutical benchmarks. Nat Biotechnol. 2014;32(10):992-1000. doi:10.1038/nbt.3040google scholar
  31. Wilson LJ. Integrating upstream and downstream process development strategies for mammalian cell derived therapeutic antibodies. University College London (UK), Doctoral Dissertation, 2020. google scholar
  32. Farid SS. Process economic drivers in industrial monoclonal antibody manufacture. In: Gottschalk U, ed. Process Scale Purification of Antibodies. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2017:445-466. doi:10.1002/9781119126942.ch21 google scholar
  33. Kaleas KA, Tripodi M, Revelli S, Sharma V, Pizarro SA. Evaluation of a multimodal resin for selective capture of CHO-derived monoclonal antibodies directly from harvested cell culture fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;969:256–263. doi:10.1016/j.jchromb.2014.08.026 google scholar
  34. Fan J, Sripada SA, Pham DN, et al. Purification of a monoclonal antibody using a novel high-capacity multimodal cation exchange nonwoven membrane. Sep Purif Technol. 2023;317:123920. doi:10.1016/j.seppur.2023.123920 google scholar
  35. Joucla G, Sénéchal CL, Begorre M, Garbay B, Santarelli X, Cabanne C. Cation exchange versus multimodal cation exchange resins for antibody capture from CHO supernatants: Identification of contaminating host cell proteins by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013; 942:126-133. doi:10.1016/j.jchromb.2013.10.033 google scholar
  36. Liu HF, Ma J, Winter C, Bayer R. Recovery and purification process development for monoclonal antibody production. MAbs. 2010;2(5):480-499. doi:10.4161/ mabs.2.5.12645 google scholar
  37. Chehraghi EJ, Akbarzadehlaleh P, Shamsasenjan K. Purification of monoclonal antibodies using chromatographic methods: Increasing purity and recovery. Adv Pharm Bul. 2025;15(1):27-45. doi:10.34172/apb.43967 google scholar